However, authorities added that the supply of vaccines to other countries needs to be balanced with their vaccination programs.
“India’s commitment to provide vaccines to other countries is valid. It has been repeated by Indian leaders. However, the main supply to other countries is India’s own supply of vaccines for national vaccination programs. We have to balance the need with the need, “said officials. PTI subject to anonymity.
India, the world’s largest producer of vaccines overall, stopped exporting COVID-19 vaccines in April to focus on inoculating its population following a surge in infections.
“We anticipate a reserve supply, and in fact after late 2021, there will be a large supply of vaccines, which will be available for export, so the situation is being closely monitored. It’s a dynamic situation. “He said.
According to people familiar with the matter, the current priority is to cover India’s eligible population effectively and in the shortest possible time.
“Export needs and commitments are also carefully monitored and monitored,” he added, adding that a coordinated approach to exporting vaccines will be taken in the future.
“India wants to fulfill its commitment to COVAX in particular,” said a person familiar with the matter.
COVAX is a global initiative aimed at equitable access to the COVID-19 vaccine supervised by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and WHO.
The Ministry of Foreign Affairs said on October 14 that the coronavirus vaccine had been sent to Nepal, Bangladesh, Myanmar and Iran following the government’s decision to resume supply.
Foreign Ministry spokesperson Arindam Bagchi said the government initially decided to send supplies to neighboring countries.
India stopped exporting COVID-19 vaccine in April.
Last month, Union Health Minister Mansuf Mandaviya announced that India would resume supplying coronavirus vaccines abroad.
“Prime Minister Narendra Modi recently said at the UN General Assembly that India would resume supplying coronavirus vaccines. We have decided to start in the neighborhood,” Baguchi said.
On October 21, India achieved a major milestone in its COVID-19 vaccination program as the cumulative dose of vaccine given in India exceeded 100 chlores.
Over 75% of India’s adult population has been vaccinated with the COVID-19 vaccine at least once, with nine states and Union Territories giving all eligible individuals a first dose.
According to Ministry of Health officials, more than 31 percent of the country’s approximately 9.3 billion rupees of adults are receiving both doses.
Currently, three vaccines are used in the country’s COVID vaccination drive: Covishield manufactured by the Serum Institute of India, Hyderabad-based Bharat Biotech’s Covaxin, and Sputnik V.
India has promised to supply the COVID-19 vaccine to other countries. Exports will begin by the end of the year, Health News, ET Health World
Source link India has promised to supply the COVID-19 vaccine to other countries. Exports will begin by the end of the year, Health News, ET Health World